FOLH1 and thyroid gland carcinoma: Specifically, histological studies have verified the expression of PSMA in the microvasculature of thyroid cancers (13, 14) where, PSMA expression was related to malignant disease, poor prognostic factors and poorer progression free survival (PFS) (15).